Y-mAbs Therapeutics
YMAB
#8231
Rank
โ‚ฌ0.16 B
Marketcap
3,64ย โ‚ฌ
Share price
0.24%
Change (1 day)
-74.54%
Change (1 year)

Earnings for Y-mAbs Therapeutics (YMAB)

Earnings in 2024 (TTM): -โ‚ฌ28.91 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ87.68 Million. a decrease over its 2023 earnings that were of -โ‚ฌ22.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Y-mAbs Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ27.49 Million21.54%
2023 -โ‚ฌ22.62 Million-72.92%
2022 -โ‚ฌ83.51 Million77.47%
2021 -โ‚ฌ47.06 Million-55.46%
2020 -โ‚ฌ0.11 Billion44.49%
2019 -โ‚ฌ73.11 Million92.01%
2018 -โ‚ฌ38.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.13 Billion 357.98%๐Ÿ‡บ๐Ÿ‡ธ USA